Skip to main content

Table 1 Characteristics of the population at the baseline evaluation

From: Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient’s perspective

Variables

Population

 

N = 149

Demographic

 

Females, N° (%)

132 (88.6%)

Age at baseline, years, mean ± SD

38.5 ± 12.8

Years of education, mean ± SD

11 ± 3.9

Marital status of the patients, N° (% of the patients)

 

Married

72 (48.3)

Single

60 (40.3)

Separated/divorced/widow

17 (11.4)

Occupation of the patients, N° (% )

 

Formal occupation

56 (37.6)

Housewife

54 (36.2)

Willing to work

20 (13.4)

Students

12 (8.1)

Informal occupation

7 (4.7)

% of health expenditures with government coverage

 

N° (%) of patients with 90% coverage

3 (2)

N° (%) of patients with 80% coverage

25 (16.8)

N° (%) of patients with 70% coverage

104 (69.8)

N° (%) of patients with 60% coverage

17 (11.4)

Disease specific autoantibodies

 

N° (%) of patients with Rheumatoid Factor

117 (78.5)

N° (%) of patients with antibodies to cyclic citrullinated proteins

117 (78.5)

Disease characteristics, median (range)

 

Disease duration, months

5 (3.2-6.8)

Disease Activity Score, 28 joints evaluated

6 (5.1-7.1)

Health Assessment Questionnaire

1.5 (0.9-2.1)

N (%) patients with ≥ 1comorbidity

88 (59.1)

Median (range) of comorbidity/patient

1 (0–1)

  1. N° = Number.
  2. SD = Standard deviation.